195 related articles for article (PubMed ID: 31879277)
1. Previsit Planning Improves Pneumococcal Vaccination Rates in Childhood-Onset SLE.
Sivaraman V; Wise KA; Cotton W; Barbar-Smiley F; AlAhmed O; MacDonald D; Lemle S; Yildirim-Toruner C; Ardoin SP; Ardura MI
Pediatrics; 2020 Jan; 145(1):. PubMed ID: 31879277
[TBL] [Abstract][Full Text] [Related]
2. Improving Pneumococcal Vaccination in Pediatric Rheumatology Patients.
Harris JG; Maletta KI; Ren B; Olson JC
Pediatrics; 2015 Sep; 136(3):e681-6. PubMed ID: 26304825
[TBL] [Abstract][Full Text] [Related]
3. Improving the Combination Pneumococcal Vaccination Rate in Systemic Lupus Erythematosus Patients at an Adult Rheumatology Practice.
Garg S; Tsagaris K; Cozmuta R; Lipson A
J Rheumatol; 2018 Dec; 45(12):1656-1662. PubMed ID: 30173154
[TBL] [Abstract][Full Text] [Related]
4. Reasons for failure to receive pneumococcal and influenza vaccinations among immunosuppressed patients with systemic lupus erythematosus.
Lawson EF; Trupin L; Yelin EH; Yazdany J
Semin Arthritis Rheum; 2015 Jun; 44(6):666-71. PubMed ID: 25701500
[TBL] [Abstract][Full Text] [Related]
5. Primary Care Physicians' Struggle with Current Adult Pneumococcal Vaccine Recommendations.
Hurley LP; Allison MA; Pilishvili T; O'Leary ST; Crane LA; Brtnikova M; Beaty BL; Lindley MC; Bridges CB; Kempe A
J Am Board Fam Med; 2018; 31(1):94-104. PubMed ID: 29330244
[TBL] [Abstract][Full Text] [Related]
6. Vaccine Update: Recommendation for conjugate pneumococcal and pneumococcal polysaccharide vaccines in adults older than 65 years.
Niemi SA; Foster SL; Hayney MS
J Am Pharm Assoc (2003); 2015; 55(2):212, 214-5. PubMed ID: 25749266
[No Abstract] [Full Text] [Related]
7. Experience with pneumococcal polysaccharide conjugate vaccine (conjugated to CRM197 carrier protein) in children and adults.
Durando P; Faust SN; Fletcher M; Krizova P; Torres A; Welte T
Clin Microbiol Infect; 2013 Oct; 19 Suppl 1():1-9. PubMed ID: 24083785
[TBL] [Abstract][Full Text] [Related]
8. Improving Pneumococcal Vaccination Rates in Rheumatology Patients by Using Best Practice Alerts in the Electronic Health Records.
Sheth HS; Grimes VD; Rudge D; Ayers B; Moreland LW; Fischer GS; Aggarwal R
J Rheumatol; 2021 Sep; 48(9):1472-1479. PubMed ID: 33323531
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of pneumococcal vaccination rates after vaccine protocol changes and nurse education in a tertiary care teaching hospital.
Smith JG; Metzger NL
J Manag Care Pharm; 2011 Nov; 17(9):701-8. PubMed ID: 22050395
[TBL] [Abstract][Full Text] [Related]
10. Impact of a guideline-based best practice alert on pneumococcal vaccination rates in adults in a primary care setting.
McAdam-Marx C; Tak C; Petigara T; Jones NW; Yoo M; Briley MS; Gunning K; Gren L
BMC Health Serv Res; 2019 Jul; 19(1):474. PubMed ID: 31291959
[TBL] [Abstract][Full Text] [Related]
11. Immunogenicity of 23-Valent Pneumococcal Vaccine in Children with Systemic Lupus Erythematosus.
Alyasin S; Adab M; Hosseinpour A; Amin R; Babaei M
Iran J Immunol; 2016 Sep; 13(3):204-19. PubMed ID: 27671512
[TBL] [Abstract][Full Text] [Related]
12. Pneumococcal Disease in the Era of Pneumococcal Conjugate Vaccine.
Yildirim I; Shea KM; Pelton SI
Infect Dis Clin North Am; 2015 Dec; 29(4):679-97. PubMed ID: 26610421
[TBL] [Abstract][Full Text] [Related]
13. Pharmacists as providers: targeting pneumococcal vaccinations to high risk populations.
Taitel M; Cohen E; Duncan I; Pegus C
Vaccine; 2011 Oct; 29(45):8073-6. PubMed ID: 21864625
[TBL] [Abstract][Full Text] [Related]
14. Long-term Impact of a "3 + 0" Schedule for 7- and 13-Valent Pneumococcal Conjugate Vaccines on Invasive Pneumococcal Disease in Australia, 2002-2014.
Jayasinghe S; Menzies R; Chiu C; Toms C; Blyth CC; Krause V; McIntyre P
Clin Infect Dis; 2017 Jan; 64(2):175-183. PubMed ID: 27986682
[TBL] [Abstract][Full Text] [Related]
15. Preventing pneumococcal disease among infants and young children. Recommendations of the Advisory Committee on Immunization Practices (ACIP).
Advisory Committee on Immunization Practices
MMWR Recomm Rep; 2000 Oct; 49(RR-9):1-35. PubMed ID: 11055835
[TBL] [Abstract][Full Text] [Related]
16. Parental knowledge, attitudes and perception of pneumococcal disease and pneumococcal conjugate vaccines in Singapore: a questionnaire-based assessment.
How CH; Phua See Chun P; Shafi F; Jakes RW
BMC Public Health; 2016 Sep; 16(1):923. PubMed ID: 27590503
[TBL] [Abstract][Full Text] [Related]
17. Impact of conjugate pneumococcal vaccines on the changing epidemiology of pneumococcal infections.
Zangeneh TT; Baracco G; Al-Tawfiq JA
Expert Rev Vaccines; 2011 Mar; 10(3):345-53. PubMed ID: 21434802
[TBL] [Abstract][Full Text] [Related]
18. A pharmacist-driven academic detailing program to increase adult pneumococcal vaccination.
Caffrey AR; DeAngelis JM; Ward KE; Orr KK; Morrill HJ; Gosciminski M; LaPlante KL;
J Am Pharm Assoc (2003); 2018; 58(3):303-310. PubMed ID: 28951137
[TBL] [Abstract][Full Text] [Related]
19. Vaccine-preventable disease incidence of pneumococcal conjugate vaccine in the Finnish invasive pneumococcal disease vaccine trial.
Palmu AA; Jokinen J; Nieminen H; Rinta-Kokko H; Ruokokoski E; Puumalainen T; Moreira M; Schuerman L; Borys D; Kilpi TM
Vaccine; 2018 Mar; 36(14):1816-1822. PubMed ID: 29503110
[TBL] [Abstract][Full Text] [Related]
20. Cost-effectiveness of conjugate pneumococcal vaccination in Singapore: comparing estimates for 7-valent, 10-valent, and 13-valent vaccines.
Tyo KR; Rosen MM; Zeng W; Yap M; Pwee KH; Ang LW; Shepard DS
Vaccine; 2011 Sep; 29(38):6686-94. PubMed ID: 21745516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
